Wolverine Asset Management’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Wolverine Asset Management’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.12K	Buy	185,437 +4,145	+2%	+$399	﹤0.01%	1443
2025 Q4	$21.8K	Sell	181,292 -15,727	-8%	-$2.54K	﹤0.01%	1361
2025 Q3	$23.6K	Buy	197,019 +5,454	+3%	+$622	﹤0.01%	1282
2025 Q2	$9.83K	Buy	191,565 +119,249	+165%	+$7.56K	﹤0.01%	1378
2025 Q1	$1.96K	Sell	72,316 -2,404	-3%	-$62	﹤0.01%	1430
2024 Q4	$388	Hold	74,720	–	–	﹤0.01%	1552
2024 Q3	$1.49K	Hold	74,720	–	–	﹤0.01%	1491
2024 Q2	$1.97K	Buy	74,720 +20,150	+37%	+$1.55K	﹤0.01%	1495
2024 Q1	$10.9K	Sell	54,570 -11,539	-17%	-$2.63K	﹤0.01%	1280
2023 Q4	$13.2K	Sell	66,109 -11,789	-15%	-$1.86K	﹤0.01%	1359
2023 Q3	$7.16K	Sell	77,898 -5,644	-7%	-$459	﹤0.01%	1521
2023 Q2	$2.33K	Buy	83,542 +200	+0.2%	+$11	﹤0.01%	1562
2023 Q1	$5.42K	Sell	83,342 -10,290	-11%	-$1.27K	﹤0.01%	1535
2022 Q4	$10.3K	Sell	93,632 -10,058	-10%	-$3.28K	﹤0.01%	1624
2022 Q3	$57K	Sell	103,690 -14,976	-13%	-$10.4K	﹤0.01%	1565
2022 Q2	$59K	Buy	118,666 +26,700	+29%	+$24.6K	﹤0.01%	1525
2022 Q1	$105K	Sell	91,966 -21,320	-19%	-$19.4K	﹤0.01%	1295
2021 Q4	$78K	Buy	+113,286	New	+$140K	﹤0.01%	1424

Other funds holding STLNW

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Wolverine Asset Management's STLNW Position: Q1 2026 in Review

Wolverine Asset Management increased its Starling Oncology, Inc. Warrant (STLNW) stake by 2.3% in Q1 2026, buying an estimated $399 and bringing the position to 185,437 shares worth $8.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1443.

Wolverine Asset Management first reported a position in STLNW in Q4 2021 and has held it in 18 quarters since. The position peaked at $105K in Q1 2022. 11 funds tracked by Wall St. Rank hold STLNW as of Q1 2026.

Wolverine Asset Management held 185,437 shares of Starling Oncology, Inc. Warrant worth $8.12K as of Q1 2026.
Wolverine Asset Management bought 4,145 Starling Oncology, Inc. Warrant shares in Q1 2026, an estimated $399.
Starling Oncology, Inc. Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1443 holding.
Wolverine Asset Management first reported a position in Starling Oncology, Inc. Warrant in Q4 2021 and has held it in 18 quarters since.
Wolverine Asset Management's Starling Oncology, Inc. Warrant position peaked at $105K in Q1 2022.
11 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.